Quantum is a leading company providing compound screening services in-silico. We apply our proprietary computational technology, QUANTUM, to identify potential strong inhibitors for a given protein target. QUANTUM shows outstanding accuracy in forecasting binding affinities of protein inhibitors. The hit rate of the QUANTUM hits is around 50%, so approximatelly half of predicted in silico strong inhibitors will be confirmed in in-vitro testing!!!
Click here to download a brochure about QUANTUM hit Identification technology.
We specialize in finding the 3D-structure of the target-protein and advise you regarding which libraries of compounds should be chosen for screening. Screening results can be delivered to you through our web-based system. Quantum can assist in analyzing drug hits and in initiating chemical synthesis programs to obtain patentable drug candidates. We deliver superior cost effective customer service and a variety of service-geared options for screening, reporting and analyzing.
General terms for a screening project:
| Size of the library of compounds |
50,000 |
| Time line for screening |
10 days |
Please, contact Quantum today to discuss your library screening project.